HGHester A. Gietema

Hester A. Gietema

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hester A. Gietema has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Discriminating dominant computed tomography phenotypes in smokers without or with mild COPD

    by Firdaus A.A. Mohamed Hoesein, Michael Schmidt, Onno M. Mets, Hester A. Gietema, Jan-Willem J. Lammers, Pieter Zanen, Harry J. de Koning, Carlijn van der Aalst, Matthijs Oudkerk, Rozemarijn Vliegenthart, et al.


  • Impact of emphysema and airway wall thickness on quality of life in smoking-related COPD

    by Hester A. Gietema, Lisa D. Edwards, Harvey O. Coxson, Per S. Bakke


  • Reply to Hochheggar et al.

    by Hester A. Gietema, Pieter Zanen, Arnold Schilham, Bram van Ginneken, Rob J. van Klaveren, Mathias Prokop, Jan Willem J. Lammers

  • Distribution of emphysema in heavy smokers: Impact on pulmonary function

    by Hester A. Gietema, Pieter Zanen, Arnold Schilham, Bram van Ginneken, Rob J. van Klaveren, Mathias Prokop, Jan Willem J. Lammers


  • Pulmonary Nodules: Interscan Variability of Semiautomated Volume Measurements with Multisection CT—Influence of Inspiration Level, Nodule Size, and Segmentation Performance

    by Hester A. Gietema, Cornelia M. Schaefer-Prokop, Willem P. T. M. Mali, Gerard Groenewegen, Mathias Prokop

    To prospectively assess the precision of semiautomated volume measurements of pulmonary nodules at low-dose multi-detector row computed tomography (CT) and to investigate the influence of nodule size, segmentation algorithm, and inspiration level. This study had institutional review board approval; written informed consent was obtained from all patients. Between June 2004 and March 2005, 20 patients (15 men, five women; age range, 40-84 years; mean age, 57 years) referred for chest CT for known lung metastases underwent two additional low-dose chest CT examinations without contrast material (collimation, 16 x 0.75 mm). Between these examinations, patients got off and on the table to simulate the conditions for a follow-up examination. Noncalcified solid pulmonary nodules between 15 and 500 mm(3) that did not abut vessel or pleura were measured in both studies by using widely applied commercial semiautomated software. Interscan variability was established with the Bland and Altman approach. The impact of nodule shape (spherical or nonspherical) on measurement variability was assessed by using one-way analysis of variance, while the contributions of mean nodule volume and change in lung volume were investigated with univariate linear regression for completely (group A) and incompletely (group B) segmented nodules. Two hundred eighteen eligible nodules (volume range, 16.4-472.7 mm(3); 106 spherical, 112 nonspherical) were evaluated. The 95% confidence interval for difference in measured volumes was -21.2%, 23.8% (mean difference, 1.3%). The precision of nodule segmentation was highly dependent on nodule shape (P < .001) and was weakly related to inspiration level for completely segmented nodules (r = -0.20; P < .047), while mean nodule volume did not show any effect (P = .15 and P = .81 for group A and B nodules, respectively). Variation of semiautomated volume measurements of pulmonary nodules can be substantial. Segmentation represents the most important factor contributing to measurement variability, while change in inspiration level has only a weak effect for completely segmented nodules.


  • Monitoring of Smoking-induced Emphysema with CT in a Lung Cancer Screening Setting: Detection of Real Increase in Extent of Emphysema

    by Hester A. Gietema, Arnold M. Schilham, Bram van Ginneken, Rob J. van Klaveren, Jan Willem J. Lammers, Mathias Prokop

    To retrospectively establish the minimum increase in emphysema score (ES) required for detection of real increased extent of emphysema with 95% confidence by using multi-detector row computed tomography (CT) in a lung cancer screening setting. The study was a substudy of the NELSON project that was approved by the Dutch Ministry of Health and the ethics committee of each participating hospital, with patient informed consent. For this substudy, original approval and informed consent allowed use of data for future research. Among 1684 men screened with low-dose multi-detector row CT (30 mAs, 16 detector rows, 0.75-mm section thickness) between April 2004 and March 2005, only participants who underwent repeat multi-detector row CT with the same scanner after 3 months because of an indeterminate pulmonary nodule were included. Extent of emphysema was considered to remain stable in this short period. Extent of low-attenuation areas representing emphysema was computed for repeat and baseline scans as percentage of lung volume below three attenuation threshold values (-910 HU, -930 HU, -950 HU). Limits of agreement were determined with Bland-Altman approach; upper limits were used to deduce the minimum increase in ES required for detecting increased extent of emphysema with 95% probability. Factors influencing the limits of agreement were determined. In total, 157 men (mean age, 60 years) were included in the study. Limits of agreement for differences in total lung volume between repeat and baseline scans were -13.4% to +12.6% at -910 HU, -4.7% to +4.2% at -930 HU, and -1.3% to +1.1% at -950 HU. Differences in ES showed weak to moderate correlation with variation in level of inspiration (r=0.20-0.49, P<.05). Scanner calibration could be excluded as a factor contributing to variation in ES. Increase in ES required to detect increased extent of smoking-related emphysema with 95% probability varies between 1.1% of total lung volume at -950 HU and 12.6% at -910 HU for low-dose multi-detector row CT. Clinical trial registration no. ISRCTN63545820.